Flagship Pioneering Inc.

Flagship Pioneering Inc. is identified as a 10% owner of Foghorn Therapeutics Inc., actively engaging in purchase activity as reflected in SEC Form 4 filings. The disclosed trading record spans from February 14, 2024, to May 24, 2024, highlighting a total of three disclosures, all of which are purchases, with reported amounts ranging from $181 to $273. The most significant transaction occurred on February 14, 2024, involving a purchase of $272.73 in shares of Sana Biotechnology, Inc. (SANA), underscoring the firm's strategic focus in the healthcare sector.